ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 149 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q3 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $246 | -10.5% | 9,646 | +0.8% | 0.00% | – |
| Q2 2023 | $275 | -25.1% | 9,574 | -37.4% | 0.00% | – |
| Q1 2023 | $367 | +41.7% | 15,300 | 0.0% | 0.00% | – |
| Q4 2022 | $259 | -99.9% | 15,300 | -0.1% | 0.00% | – |
| Q3 2022 | $227,000 | -5.4% | 15,309 | +0.3% | 0.00% | – |
| Q2 2022 | $240,000 | -41.7% | 15,260 | -0.1% | 0.00% | – |
| Q1 2022 | $412,000 | -27.1% | 15,274 | -0.0% | 0.00% | -100.0% |
| Q4 2021 | $565,000 | -22.8% | 15,279 | -0.2% | 0.00% | 0.0% |
| Q3 2021 | $732,000 | +21.0% | 15,314 | -14.3% | 0.00% | 0.0% |
| Q2 2021 | $605,000 | -22.0% | 17,868 | -5.0% | 0.00% | 0.0% |
| Q1 2021 | $776,000 | -10.1% | 18,800 | -5.5% | 0.00% | 0.0% |
| Q4 2020 | $863,000 | +67.6% | 19,900 | +65.8% | 0.00% | 0.0% |
| Q3 2020 | $515,000 | -8.2% | 12,000 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $561,000 | – | 12,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 208,886 | $5,337,037 | 1.71% |
| Portolan Capital Management | 276,505 | $7,064,703 | 0.66% |
| Nikko Asset Management Americas, Inc. | 1,388,574 | $35,422,523 | 0.42% |
| Green Alpha Advisors, LLC | 21,538 | $550,296 | 0.42% |
| SummerHaven Investment Management, LLC | 22,326 | $570,429 | 0.42% |
| ARK Investment Management | 1,901,546 | $48,584,508 | 0.37% |
| Granahan Investment Management | 398,862 | $10,190,924 | 0.36% |
| FEDERATED HERMES, INC. | 4,711,512 | $120,379,132 | 0.32% |
| Woodline Partners LP | 1,069,814 | $27,333,748 | 0.32% |
| Diametric Capital, LP | 26,130 | $667,621 | 0.28% |